Kestra Medical Technologies (KMTS) Non-Current Debt (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Non-Current Debt data on file, last reported at $42.3 million in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $42.3 million, down 3.4% year-over-year; the trailing twelve-month figure through Jan 2026 was $42.3 million (down 3.4% YoY), and the FY2025 annual result was $41.1 million, down 3.38% from the prior year.
• Non-Current Debt grew to $42.3 million in Q1 2026 per KMTS's latest filing, from $41.9 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $43.7 million in Q1 2025 and troughed at $41.1 million in Q2 2025.
• A 3-year average of $42.2 million and a median of $42.1 million in 2025 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2025 and 2026: Non-Current Debt slipped 3.38% in 2025, then declined 3.4% in 2026.
• A 3-year view of Non-Current Debt shows it stood at $42.5 million in 2024, then dropped by 1.56% to $41.9 million in 2025, then rose by 0.93% to $42.3 million in 2026.
• Business Quant data shows KMTS's Non-Current Debt at $42.3 million in Q1 2026, $41.9 million in Q4 2025, and $41.5 million in Q3 2025.